研究亮点1.在循环肿瘤 DNA（ctDNA）指导下可以减少辅助化疗的使用，但不增加复发风险；2.ctDNA 指导治疗可以获得与标准治疗相似的总生存期（OS）结果，可有效取代传统治疗决策；3.与单药氟尿嘧啶类药物相比，奥沙利铂双药化疗的 ctDNA ...

皇家马斯登医院自2018年开始进行肿瘤NGS检测项目，每年的NGS检测量超过3万例，全自动化检测和人工智能已经渗透到分子检测的各个环节。在英国绝大多数患者的治疗方案都需要结合NGS检测结果和多学科团队（MDT）讨论来制定，但是NGS检测时间通常需要一 ...

为解决 I 期肿瘤药物临床试验问题，研究人员探索 ctDNA 应用，发现其可助力决策 ... 他们的研究成果发表在《Journal of Experimental & Clinical Cancer Research》杂志上，为肿瘤药物开发带来了新的曙光。 研究人员采用了多种关键技术方法。在检测肿瘤分数（TF）方面 ...

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

SPOT-MAS aims to improve this by providing a reliable, non-invasive, multi-cancer blood test. The test incorporates next-generation sequencing (NGS) and artificial intelligence technologies to detect ...

If detected early, cancer is much easier to treat. Emerging non-invasive tests can help early diagnosis. As diseases go, cancer is deadly. Its early detection, however, can make a huge difference to ...

Among patients with curatively resected early-stage biliary tract cancer (BTC), recent study findings from a real-world cohort trial revealed the value of circulating tumor DNA (ctDNA) as a prognostic ...

A recent study has shown that analysis of ctDNA methylation can aid the early diagnosis of non-small cell lung cancer (NSCLC) ...